318 related articles for article (PubMed ID: 29066258)
21. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
[TBL] [Abstract][Full Text] [Related]
22. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
[TBL] [Abstract][Full Text] [Related]
23. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
Zipursky RB; Odejayi G; Agid O; Remington G
Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
[TBL] [Abstract][Full Text] [Related]
24. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
[TBL] [Abstract][Full Text] [Related]
25. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
[TBL] [Abstract][Full Text] [Related]
26. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
27. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
28. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
[TBL] [Abstract][Full Text] [Related]
29. Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis.
Hayes JF; Osborn DP; Lundin A; Dalman C
J Psychopharmacol; 2019 Apr; 33(4):532-534. PubMed ID: 30777499
[TBL] [Abstract][Full Text] [Related]
30. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
31. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
Üçok A; Kara İA
Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
[TBL] [Abstract][Full Text] [Related]
32. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
Asian Network of Early Psychosis Writing Group
Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
[TBL] [Abstract][Full Text] [Related]
34. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
[TBL] [Abstract][Full Text] [Related]
35. Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success.
Larsen-Barr M; Seymour F; Read J; Gibson K
Psychiatry Res; 2018 Dec; 270():365-374. PubMed ID: 30300866
[TBL] [Abstract][Full Text] [Related]
36. Visual working memory deterioration preceding relapse in psychosis.
Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
[TBL] [Abstract][Full Text] [Related]
37. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
[TBL] [Abstract][Full Text] [Related]
38. Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.
Daneault JG; Maraj A; Lepage M; Malla A; Schmitz N; Iyer SN; Joober R; Shah JL
Acta Psychiatr Scand; 2019 Apr; 139(4):336-347. PubMed ID: 30712261
[TBL] [Abstract][Full Text] [Related]
39. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
Moncrieff J
Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
[TBL] [Abstract][Full Text] [Related]
40. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
